patient in intramuscular arm provide appointments for injections Visit 2 (week 8) Anamnesis: record lifestyle habits and use of alcohol Symptoms: if pathological at the first visit, record paresthesia, asthenia, loss or reduction of appetite, sadness or change in level of happiness, and concomitant pharmacological treatment Physical examination: if pathological at the first visit examine for Hunters glositis, positional and vibrational sensitivity Record concomitant treatment Request analyses to be performed one week before next visit: haemogram and serum vitamin B12 Questionnaires: EuroQoL-5D Assessment of adverse effects Therapeutic plan: patient in oral arm provision of medication
Gualtieri R, et al
Were ready to help you take the next step with clarity, compassion, and real medical support
This post covers the safety protocols for shifting your dose, the physiological reasons behind the 72-hour rule, and how to maintain progress while adjusting your routine
Two GLP-1s are FDA-approved for long-term weight management: the once-weekly Wegovy and the daily-dose Saxenda (liraglutide)
Patients can start semaglutide injection at $189/mo (or $149/mo on the 6-month plan) only after physician approval, ensuring personalized safety assessment